153 related articles for article (PubMed ID: 37986081)
1. The impact of erythroblast enucleation efficiency on the severity of anemia in patients with myelodysplastic syndrome.
An C; Xue F; Sun L; Han H; Zhang Y; Hu Y
Cell Commun Signal; 2023 Nov; 21(1):332. PubMed ID: 37986081
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between ultrastructural abnormality of bone marrow cells and anemia and neutropenia in myelodysplastic syndrome].
Zhang HM; Liu JH; Zhao SX; Dong SX; Zhu XF; Ru YX; Xiao ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):81-4. PubMed ID: 21362227
[TBL] [Abstract][Full Text] [Related]
3. CD47 is expressed abnormally on hematopoietic cells in myelodysplastic syndrome.
Jiang H; Fu R; Wang H; Li L; Liu H; Shao Z
Leuk Res; 2013 Aug; 37(8):907-10. PubMed ID: 23642736
[TBL] [Abstract][Full Text] [Related]
4. Role of Plasma Gelsolin Protein in the Final Stage of Erythropoiesis and in Correction of Erythroid Dysplasia In Vitro.
Han SY; Lee EM; Kim S; Kwon AM; Baek EJ
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992584
[TBL] [Abstract][Full Text] [Related]
5. Enhancing mitochondrial function in vivo rescues MDS-like anemia induced by pRb deficiency.
Sen T; Jain M; Gram M; Mattebo A; Soneji S; Walkley CR; Singbrant S
Exp Hematol; 2020 Aug; 88():28-41. PubMed ID: 32629063
[TBL] [Abstract][Full Text] [Related]
6. Abnormal CD25 expression on hematopoietic cells in myelodysplastic syndromes.
Liu P; Jiang H; Che M; Fu R; Wang H; Li L; Zhang W; Tao J; Gao S; Shao Z
Leuk Res; 2018 Apr; 67():12-16. PubMed ID: 29407181
[TBL] [Abstract][Full Text] [Related]
7. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
8. Anti-erythroblast autoimmunity in early myelodysplastic syndromes.
Barcellini W; Zaninoni A; Imperiali FG; Boschetti C; Colombi M; Iurlo A; Zanella A
Haematologica; 2007 Jan; 92(1):19-26. PubMed ID: 17229631
[TBL] [Abstract][Full Text] [Related]
9. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.
Tehranchi R; Invernizzi R; Grandien A; Zhivotovsky B; Fadeel B; Forsblom AM; Travaglino E; Samuelsson J; Hast R; Nilsson L; Cazzola M; Wibom R; Hellström-Lindberg E
Blood; 2005 Jul; 106(1):247-53. PubMed ID: 15755901
[TBL] [Abstract][Full Text] [Related]
10. The expression of transferrin receptors on erythroblasts in anaemia of chronic disease, myelodysplastic syndromes and iron deficiency.
Kuiper-Kramer PA; Huisman CM; Van der Molen-Sinke J; Abbes A; Van Eijk HG
Acta Haematol; 1997; 97(3):127-31. PubMed ID: 9066706
[TBL] [Abstract][Full Text] [Related]
11. Low RPS14 expression in MDS without 5q - aberration confers higher apoptosis rate of nucleated erythrocytes and predicts prolonged survival and possible response to lenalidomide in lower risk non-5q- patients.
Wu L; Li X; Xu F; Zhang Z; Chang C; He Q
Eur J Haematol; 2013 Jun; 90(6):486-93. PubMed ID: 23506134
[TBL] [Abstract][Full Text] [Related]
12. The effects of azacitidine on the response and prognosis of myelodysplastic syndrome and acute myeloid leukemia involving a bone marrow erythroblast frequency of >50.
Uchida T; Hagihara M; Hua J; Inoue M
Leuk Res; 2017 Feb; 53():35-38. PubMed ID: 28013105
[TBL] [Abstract][Full Text] [Related]
13. Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.
Rosenberg CA; Bill M; Rodrigues MA; Hauerslev M; Kerndrup GB; Hokland P; Ludvigsen M
Cytometry B Clin Cytom; 2021 Sep; 100(5):554-567. PubMed ID: 33285035
[TBL] [Abstract][Full Text] [Related]
14. [NIX-mediated mitochondrial autophagy in pathogenesis of myelodysplastic syndrome anemia].
Yang LY; Cui NB; Wang HQ; Fu R; Qu W; Ruan EB; Wang XM; Wang GJ; Wu YH; Liu H; Song J; Guan J; Xing LM; Li LJ; Jiang HJ; Liu H; Wang YH; Liu CY; Zhang W; Shao ZH
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(14):1071-1075. PubMed ID: 28395431
[No Abstract] [Full Text] [Related]
15. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.
Arenillas L; Calvo X; Luño E; Senent L; Alonso E; Ramos F; Ardanaz MT; Pedro C; Tormo M; Marco V; Montoro J; Díez-Campelo M; Brunet S; Arrizabalaga B; Xicoy B; Andreu R; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
J Clin Oncol; 2016 Sep; 34(27):3284-92. PubMed ID: 27382099
[TBL] [Abstract][Full Text] [Related]
16. [Study on the implications of erythroblasts periodic acid-Schiff stain in myelodysplastic syndromes].
Liu L; Cui W; Zhang HL; Xu ZF; Zhang FK; Zheng YZ; Zhang Y; Qin TJ; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):259-64. PubMed ID: 21569710
[TBL] [Abstract][Full Text] [Related]
17. Disruption of erythroid nuclear opening and histone release in myelodysplastic syndromes.
Zhao B; Liu H; Mei Y; Liu Y; Han X; Yang J; Wickrema A; Ji P
Cancer Med; 2019 Mar; 8(3):1169-1174. PubMed ID: 30701702
[TBL] [Abstract][Full Text] [Related]
18. Ratio of bone marrow reticulocytes to peripheral corrected reticulocytes for evaluating ineffective erythropoiesis.
Choi JW
Ann Clin Lab Sci; 2006; 36(4):439-41. PubMed ID: 17127730
[No Abstract] [Full Text] [Related]
19. Impaired Mitophagy of Nucleated Erythroid Cells Leads to Anemia in Patients with Myelodysplastic Syndromes.
Jiang H; Yang L; Guo L; Cui N; Zhang G; Liu C; Xing L; Shao Z; Wang H
Oxid Med Cell Longev; 2018; 2018():6328051. PubMed ID: 29967662
[TBL] [Abstract][Full Text] [Related]
20. Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.
Sundaravel S; Duggan R; Bhagat T; Ebenezer DL; Liu H; Yu Y; Bartenstein M; Unnikrishnan M; Karmakar S; Liu TC; Torregroza I; Quenon T; Anastasi J; McGraw KL; Pellagatti A; Boultwood J; Yajnik V; Artz A; Le Beau MM; Steidl U; List AF; Evans T; Verma A; Wickrema A
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6359-68. PubMed ID: 26578796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
